Dublin, Ireland

Luke A J O'Neill

This inventor holds 1 USPTO granted patent. Top assignee: Immunex Corporation. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luke A J O'Neill. Retrieved from https://idiyas.com/inventor/luke-a-j-o-neill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Luke A J O'Neill

Introduction

Luke A J O'Neill is a prominent inventor based in Dublin, Ireland. He is known for his contributions to the field of biotechnology, particularly in the development of polypeptides and their applications. His work has significant implications for medical research and therapeutic development.

Latest Patents

O'Neill holds a patent for MyD88 adapter-like proteins. This patent includes the disclosure of MAL-1 polypeptides and active fragments of MAL-1, which are known to associate with IRAK2. Additionally, the patent covers DNAs encoding these polypeptides and fragments, along with methods for utilizing them in various applications.

Career Highlights

O'Neill is associated with Immunex Corporation, where he has been able to leverage his expertise in biotechnology. His work at the company has allowed him to focus on innovative solutions that address complex biological challenges.

Collaborations

Throughout his career, O'Neill has collaborated with notable colleagues, including John Ernest Sims and Timothy A Bird. These collaborations have further enriched his research and contributed to advancements in the field.

Conclusion

Luke A J O'Neill's innovative work in biotechnology, particularly his patent on MyD88 adapter-like proteins, showcases his significant contributions to the scientific community. His collaborations and career at Immunex Corporation highlight his commitment to advancing medical research and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…